Spatial OMICS Market Size, Share and Analysis 2034
Spatial OMICS Market Growth, Size, Trends Analysis - By Technology, By Product, By Application, By Workflow, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Oct-2025 | Report ID: BIOT2507 | Pages: 1 - 257 | Formats*: |
| Category : Biotechnology | |||
Spatial OMICS Market Introduction and Overview
According to SPER Market Research, the Global Spatial OMICS Market is estimated to reach USD 3253.89 million by 2034 with a CAGR of 16.52%.
The report includes an in-depth analysis of the Global Spatial OMICS Market, including market size and trends, product mix, Applications, and supplier analysis. The global spatial omics market was valued at approximately USD 705.34 million in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 16.52% from 2025 to 2034. This market growth is fueled by various factors, such as the increasing incidence of diverse genetic disorders, advancements in sequencing technologies worldwide, and heightened investment in OMICS research. Additionally, the spatial OMICS market is expected to grow due to its rising application in drug research and development, as well as its potential utility in cancer diagnostics.
By Technology Insights:
The technology-based market is divided into spatial transcriptomics, spatial genomics, and spatial proteomics. In 2024, the spatial transcriptomics segment was the leading segment in the market. This segment maintains a significant market share owing to its capability to deliver a thorough understanding of the spatial organization of gene expression within tissues. Furthermore, the rising applicability in cancer research, neuroscience, developmental biology, and immunology contributes to the growth of this segment.
By Product Insights:
The spatial OMICS market is categorized based on product into instruments, consumables, and software. In 2024, the consumables sector dominated the market. Consumables, including reagents, probes, and assay kits, are vital for spatial OMICS methodologies, as they facilitate researchers in accurately examining the spatial distribution of biomolecules within tissues or cells. These elements are critical for sample preparation and analysis. Additionally, the growing adoption of spatial OMICS technologies across various research fields, such as cancer research, neuroscience, and developmental biology, is propelling the demand for consumables.
By Application Insights:
In terms of application, the spatial OMICS market is segmented into diagnostics, translation research, drug discovery and development, single-cell analysis, cell biology, and other applications. The diagnostics segment was the dominant force in the market in 2024. This significant growth in the segment can be linked to the increasing adoption of spatial OMICS technologies in both research and clinical environments, particularly in the fields of oncology and neurology, where spatially resolved molecular data is crucial for comprehending disease mechanisms, identifying biomarkers, and formulating targeted therapies. Moreover, advancements in spatial OMICS platforms, including enhanced imaging resolution, multiplexing capabilities, and improved data analysis tools, are further promoting the segment's growth.
By Workflow Insights:
The spatial OMICS market, categorized by workflow, is divided into sample preparation, instrumental analysis, and data analysis. In 2024, the sample preparation segment led the market. Sample preparation encompasses a range of processes, including tissue fixation, embedding, sectioning, and staining, all of which are crucial for maintaining spatial information and readying samples for analysis. Consequently, as spatial OMICS technologies progress, the need for effective and dependable sample preparation methods is on the rise. Furthermore, the increasing implementation of spatial OMICS techniques across various fields, such as cancer research and developmental biology, is further driving the demand for sample preparation.
By End-User Insights:
The spatial OMICS market, classified by end-user, is segmented into academic and research institutes, pharmaceutical and biotechnology companies, Contract Research Organizations, and other end-users. The academic and research institutes segment was the market leader in 2024. These institutes act as centers for innovative research, attracting leading scientists and promoting partnerships with industry stakeholders. Their significant funding, access to advanced equipment, and strong emphasis on interdisciplinary research render them ideal collaborators for the development and validation of spatial OMICS technologies.
Regional Insights:
In 2024, the North American spatial OMICS market held the largest share. Contributing factors to this significant market share include the rising cancer prevalence, an increasing demand for personalized medicine, well-established healthcare infrastructure, and the availability of innovative diagnostic methods. The escalating morbidity and mortality rates associated with cancer and other metabolic, autoimmune, and inflammatory diseases have intensified the need for the development of new therapies, thereby propelling market growth in this region.
Market Competitive Landscape:
The spatial OMICS sector is marked by the presence of several prominent players who provide cutting-edge products. Common strategies employed by these players to enhance their market presence include strategic partnerships, mergers, and acquisitions, which help them expand their service offerings and secure a competitive edge. Notable companies operating in this market include Bruker, 10x Genomics, Danaher, Akoya Biosciences, Bio-Techne, among others.
Recent Developments:
In February 2025, Illumina, Inc. unveiled a new spatial technology initiative, enabling researchers to map intricate tissues and comprehend cellular behavior on an unprecedented scale. Illumina’s spatial technology offers unbiased whole-transcriptome profiling with cellular resolution and exceptional sensitivity.
In November 2024, Bruker Corporation introduced EpicIF, an innovative fluorescence signal removal technology that significantly improves its CellScape Spatial Proteomics platform. EpicIF broadens the spectrum of compatible fluorophore-conjugated antibodies by nearly tenfold, streamlines assay development, and doubles throughput, all while maintaining tissue integrity and preventing cross-reactivity.
In October 2024, Vizgen, Inc. announced a partnership with Ultivue, Inc. to propel future technological advancements in spatial multi-omics. This collaboration aims to merge Vizgen’s expertise in single-cell spatial genomics with Ultivue’s leadership in multiplex proteomic profiling.
In November 2023, 10x Genomics and OWKIN joined forces to integrate 10x Genomics single-cell technologies and spatial omics into the MOSAIC project.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Technology, By Product, By Application, By Workflow, By End-User |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | 10x Genomics, Akoya Biosciences, Inc, Bio-Techne Corporation, BioSpyder, Inc, Bruker Corporation, Danaher Corporation, Diagenode Diagnostics (Hologic, Inc), Ionpath, Inc, Millennium Science Pty Ltd, NanoString Technologies, Inc. |
- Global Spatial OMICS Market Size (FY 2021-FY 2034)
- Overview of Spatial OMICS Fiber Market
- Segmentation of Global Spatial OMICS Market By Technology (Spatial transcriptomics, Spatial genomics, Spatial proteomics)
- Segmentation of Global Spatial OMICS Market By Product (Instruments, Consumable, Software)
- Segmentation of Global Spatial OMICS Market By Application (Diagnostics, Translation research, Drug discovery and development, Single cell analysis, Cell biology, other application)
- Segmentation of Global Spatial OMICS Market By Workflow (Sample preparation
- Instrumental analysis, Data analysis)
- Segmentation of Global Spatial OMICS Market By End-User (Academic & research institutes, Pharmaceutical and biotechnology companies, Contract research organizations, Other end-users)
- Expansion Analysis of Global Spatial OMICS Market
- Problems and Obstacles in Global Spatial OMICS Market
- Competitive Landscape in the Global Spatial OMICS Market
- Details on Current Investment in Global Spatial OMICS Market
- Competitive Analysis of Global Spatial OMICS Market
- Prominent Players in the Global Spatial OMICS Market
- SWOT Analysis of Global Spatial OMICS Market
- Global Spatial OMICS Market Future Outlook and Projections (FY 2025-FY 2034)
- Recommendations from Analyst
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. Global Spatial OMICS Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Spatial OMICS Market
7. Global Spatial OMICS Market, By Technology (USD Million) 2021-2034
- 7.1. Spatial transcriptomics
- 7.2. Spatial genomics
- 7.3. Spatial proteomics
8. Global Spatial OMICS Market, By Product (USD Million) 2021-2034
- 8.1. Instruments
- 8.1.1. Sequencing platforms
- 8.1.2. IHC
- 8.1.3. Microscopy
- 8.1.4. Flow cytometry
- 8.1.5. Mass spectrometry
- 8.1.6. Other types
- 8.2. Consumables
- 8.3. Software
- 8.3.1. Bioinformatics tools
- 8.3.2. Imaging tools
- 8.3.3. Storage & management databases
9. Global Spatial OMICS Market, By Application (USD Million) 2021-2034
- 9.1. Diagnostics
- 9.2. Translation research
- 9.3. Drug discovery and development
- 9.4. Single cell analysis
- 9.5. Cell biology
- 9.6. Other applications
10. Global Spatial OMICS Market, By Workflow (USD Million) 2021-2034
- 10.1. Sample preparation
- 10.2. Instrumental analysis
- 10.3. Data analysis
11. Global Spatial OMICS Market, By End-User (USD Million) 2021-2034
- 11.1. Academic & research institutes
- 11.2. Pharmaceutical and biotechnology companies
- 11.3. Contract research organizations
- 11.4. Other end-users
12. Global Spatial OMICS Market, (USD Million) 2021-2034
- 13.1. Global Spatial OMICS Market Size and Market Share
13. Global Spatial OMICS Market, By Region, (USD Million) 2021-2034
- 13.1. Asia-Pacific
- 13.1.1. Australia
- 13.1.2. China
- 13.1.3. India
- 13.1.4. Japan
- 13.1.5. South Korea
- 13.1.6. Rest of Asia-Pacific
- 13.2. Europe
- 13.2.1. France
- 13.2.2. Germany
- 13.2.3. Italy
- 13.2.4. Spain
- 13.2.5. United Kingdom
- 13.2.6. Rest of Europe
- 13.3. Middle East and Africa
- 13.3.1. Kingdom of Saudi Arabia
- 13.3.2. United Arab Emirates
- 13.3.3. Qatar
- 13.3.4. South Africa
- 13.3.5. Egypt
- 13.3.6. Morocco
- 13.3.7. Nigeria
- 13.3.8. Rest of Middle-East and Africa
- 13.4. North America
- 13.4.1. Canada
- 13.4.2. Mexico
- 13.4.3. United States
- 13.5. Latin America
- 13.5.1. Argentina
- 13.5.2. Brazil
- 13.5.3. Rest of Latin America
14. Company Profile
- 14.1. 10x Genomics
- 14.1.1. Company details
- 14.1.2. Financial outlook
- 14.1.3. Product summary
- 14.1.4. Recent developments
- 14.2. Akoya Biosciences, Inc
- 14.2.1. Company details
- 14.2.2. Financial outlook
- 14.2.3. Product summary
- 14.2.4. Recent developments
- 14.3. Bio-Techne Corporation
- 14.3.1. Company details
- 14.3.2. Financial outlook
- 14.3.3. Product summary
- 14.3.4. Recent developments
- 14.4. BioSpyder, Inc
- 14.4.1. Company details
- 14.4.2. Financial outlook
- 14.4.3. Product summary
- 14.4.4. Recent developments
- 14.5. Bruker Corporation
- 14.5.1. Company details
- 14.5.2. Financial outlook
- 14.5.3. Product summary
- 14.5.4. Recent developments
- 14.6. Danaher Corporation
- 14.6.1. Company details
- 14.6.2. Financial outlook
- 14.6.3. Product summary
- 14.6.4. Recent developments
- 14.7. Diagenode Diagnostics (Hologic, Inc)
- 14.7.1. Company details
- 14.7.2. Financial outlook
- 14.7.3. Product summary
- 14.7.4. Recent developments
- 14.8. Ionpath, Inc
- 14.8.1. Company details
- 14.8.2. Financial outlook
- 14.8.3. Product summary
- 14.8.4. Recent developments
- 14.9. Millennium Science Pty Ltd
- 14.9.1. Company details
- 14.9.2. Financial outlook
- 14.9.3. Product summary
- 14.9.4. Recent developments
- 14.10. NanoString Technologies, Inc
- 15.10.1. Company details
- 15.10.2. Financial outlook
- 15.10.3 Product summary
- 15.10.4. Recent developments
- 14.11. Others
15. Conclusion
16. List of Abbreviations
17. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Spatial OMICS Market is projected to reach USD 3253.89 million by 2034, growing at a CAGR of of 16.52% during the forecast period.
Spatial OMICS Market grew in Market size from 2025. The Market is expected to reach USD 3253.89 million by 2034, at a CAGR of 16.52 billion% during the forecast period.
Spatial OMICS Market CAGR of 16.52% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Spatial OMICS Market size is USD 3253.89 million from 2025 to 2034.
Spatial OMICS Market is covered By Technology, By Product, By Application, By Workflow, By End-User
The North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa is the highest Market share in the Spatial OMICS Market.
10x Genomics, Akoya Biosciences, Inc, Bio-Techne Corporation, BioSpyder, Inc, Bruker Corporation, Danaher Corporation, Diagenode Diagnostics (Hologic, Inc), Ionpath, Inc, Millennium Science Pty Ltd, NanoString Technologies, Inc.
The report includes an in-depth analysis of the Global Spatial OMICS Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
